A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia

Not Applicable

Completed

• Conditions: Chronic Lymphocytic Leukemia
• Interventions: Other: Education Intervention

• Registration Number: NCT02619604
• Lead Sponsor: Duke University

Brief Summary

This project addresses the need to improve physician knowledge and clinical practice patterns related to quality of life (QoL) concerns for patients with chronic lymphocytic leukemia (CLL).

Detailed Description

This multifaceted initiative will include evaluating patient perspectives on their QoL, evaluating provider perspectives on managing QoL, and providing education to the whole CLL care team (hematologists/oncologists, nurse practitioners, physician assistants, and nurses) on contemporary approaches for individualized, patient-centered management of CLL. Providers, including physicians, nurse practitioners, and physician assistants will participate in educational initiatives geared towards enhancing their knowledge and confidence with managing QoL concerns for patients with CLL. Pre and post surveys will be conducted with providers to evaluate change in these areas. The project aims to train this team on how to enhance communication with patients and caregivers as a means to increase patient engagement in care and QoL in this population.

Study Timeline

• Study First Submitted: 2015-11-30
• Study First Submitted QC: 2015-11-30
• Study First Posted: 2015-12-02
• Study Start: 2016-05
• Status Verified: 2017-01
• Primary Completion: 2017-02
• Study Completion: 2017-02
• Last Update Submitted: 2017-02-14
• Last Update Posted: 2017-02-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Clinician

• Participant must be a hematologist, oncologist, nurse practitioner, or physician assistant who practices medicine in the Duke Cancer Network
• Participant treats patients with CLL
• Participant is willing to participate in the educational component of this project

Inclusion Criteria: Patient

• Patient has a diagnosis of Chronic Lymphocytic Leukemia
• Patient is over the age of 18
• Patient is being treated at a Duke Cancer Network affiliate site,
• Patient is expected to see their physician or another member of their care team at least 3 times annually.
• Signed informed consent

Exclusion Criteria

Clinician

• None

Exclusion Criteria: Patient

• Patient is Non-English speaking
• Patient diagnosed with CLL < 60 days ago

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Clinician education	Education Intervention	-

Primary Outcome Measures

Name	Time	Method
Change in provider knowledge with management of Quality of Life Concerns for CLL patients, as measured by survey	Baseline, 6 months
Change in provider confidence with management of Quality of Life Concerns for CLL patients, as measured by survey	Baseline, 6 months

Trial Locations

Locations (1)

Duke Cancer Network; 🇺🇸 Durham, North Carolina, United States